Evidence map›Paper›PMID 42427836›Full record

ArticleResearch square2026

Timing of menstrual cups to prevent transition from optimal to not optimal vaginal microbiome community state type: Results from a 6.5-year prospective observational cohort.

Supriya D Mehta, Garazi Zulaika, Souvik Paul, Walter Agingu, Ezekiel Dibondo, Johanna B Holm, Stefan J Green, Anna Maria van Eijk, Sanjib Basu, Fredrick Otieno and 1 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Supriya D MehtaDivision of Infectious Disease Medicine, Rush University College of Medicine, 1750 W. Harrison Street, Jelke 1121; Chicago, USA.
Garazi ZulaikaDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK, Liverpool, UK.
Souvik PaulDivision of Epidemiology & Biostatistics, University of Illinois Chicago School of Public Health, 1603 W. Taylor Street, 958; Chicago, USA.
Walter AginguNyanza Reproductive Health Society, UNIM Research and Training Centre off Stadium Road at Lumumba Sub-County Hospital; Kisumu, Nyanza Province, 40100, Kenya.
Ezekiel DibondoNyanza Reproductive Health Society, UNIM Research and Training Centre off Stadium Road at Lumumba Sub-County Hospital; Kisumu, Nyanza Province, 40100, Kenya.
Johanna B HolmCenter for Advanced Microbiome Research and Innovation, Institute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, 670 W. Baltimore Street, Rm 3117; University of Maryland Baltimore, School of Medicine; Baltimore, MD, 21201, USA.
Stefan J GreenDivision of Infectious Disease Medicine, Rush University College of Medicine, 1750 W. Harrison Street, Jelke 1121; Chicago, USA.
Anna Maria van EijkDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK, Liverpool, UK.
Sanjib BasuDivision of Epidemiology & Biostatistics, University of Illinois Chicago School of Public Health, 1603 W. Taylor Street, 958; Chicago, USA.
Fredrick OtienoNyanza Reproductive Health Society, UNIM Research and Training Centre off Stadium Road at Lumumba Sub-County Hospital; Kisumu, Nyanza Province, 40100, Kenya.
Penelope A Phillips-HowardDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK, Liverpool, UK.

Funding

Increased risk of STI and HIV among adolescent girls and young women due to COVID-19 and pandemic mitigation: Biological, behavioral, and psychosocial mediatorsR01HD106822 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, SUPRIYA DINESH · 2021 to 2024
$2.5M
Menstrual cups, maturation of the adolescent vaginal microbiome, and STI/HIV riskR01HD093780 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MEHTA, SUPRIYA DINESH · 2018 to 2021
$1.9M
Integrating multi-omics data: Modeling biomarkers and mechanisms to reduce bacterial vaginosis recurrenceK01AI163413 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HOLM, JOHANNA B. · 2021 to 2025
$464k
NIAID NIH HHS K01 AI163413NICHD NIH HHS R01 HD093780NICHD NIH HHS R01 HD106822Wellcome Trust
6 · The paper itself

Abstract

Background: In a cluster randomized trial among Kenyan secondary schoolgirls, menstrual cups were associated with reduced bacterial vaginosis (BV) and increased optimal vaginal microbiome (VMB) community state type (CST-I) prevalence. The prevalence of CST-I decreased over time, suggesting non-optimal VMB is acquired. Using 6.5 years follow-up, we identified how menstrual cups and other factors drive CST transition. Methods: Participants were randomized to receive menstrual cups (intervention) or standard menstrual management (control). VMB and BV were measured 6-monthly and sexually transmitted infections (STIs; gonorrhea, chlamydia, trichomoniasis) and HSV-2 annually. Control participants received menstrual cups after the 30-month study visit. Continuous-time multi-state Markov modeling estimated the probability of CST transition, focusing on optimal CST-I ( Findings: Over 6.5 years, in 4,446 observations among 436 participants, CST-I prevalence decreased from 43.3% at baseline to 13.9%, and CST-IV increased from 18.1% at baseline to 44.6%. CST-I and CST-IV were more stable than CST-III. The probability of transition to CST-I from CST-III (16%) or CST-IV (9%) was infrequent. Participants initially randomized to menstrual cups had 54% reduced risk of transitioning from CST-I to CST-IV, adjusted for demographic and behavioral practices, BV, STIs, and HSV-2. Those who were poorer, older, sexually active, and HSV-2 seropositive were more likely to transition to less optimal CSTs. Interpretation: Over 6.5 years of observation, menstrual cups helped maintain CST-I VMB but did not demonstrate any therapeutic effect and should therefore be given to girls prior to sexual exposure to maximize the likelihood of achieving this benefit.

Indexed as

Bacterial vaginosiscommunity state typeHSV-2LactobacillusMarkov modelmenstrual cupsmenstrual healthsexually transmitted infectionvaginal microbiome

Identifiers

PMID42427836
PMCPMC13345564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.